Infection with Opisthorchis viverrini and use of praziquantel among a working-age population in Northeast Thailand

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 2963-2966

  Saengsawang, Phubet ^a,b   Promthet, Supannee ^a   Bradshaw, Peter ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b Yasothon Province   (Thailand)

Author keywords

Northeast Thailand; Opisthorchis viverrini; Praziquantel; Working age population

Indexed keywords

ANTHELMINTIC AGENT; PRAZIQUANTEL;

ADULT; AGED; ANIMAL; BILE DUCT CARCINOMA; CROSS-SECTIONAL STUDY; DIET; DRUG EFFECTS; EPIDEMIOLOGY; FEEDING BEHAVIOR; FEMALE; HUMAN; MALE; MIDDLE AGED; OPISTHORCHIASIS; OPISTHORCHIS; PARASITOLOGY; PATHOGENICITY; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; RURAL POPULATION; THAILAND; YOUNG ADULT;

ADULT; AGED; ANIMALS; ANTHELMINTICS; CHOLANGIOCARCINOMA; CROSS-SECTIONAL STUDIES; DIET; FEMALE; FOOD HABITS; HUMANS; MALE; MIDDLE AGED; OPISTHORCHIASIS; OPISTHORCHIS; PRAZIQUANTEL; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; RURAL POPULATION; THAILAND; YOUNG ADULT;

EID: 84880346109     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.2963     Document Type: Article

References (30)

1. Andrews RH, Sithithaworn P, Petney TN (2008). Opisthorchis viverrini: an underestimated parasite in the world. Trends in Parasitology, 24, 497-501.
2. Boonmars T, Srisawangwong T, Srirach P, et al (2007). Apoptosis- related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel. Parasitol Res, 102, 57-62.
3. Bureau of Epidemiology, Ministry of Public Health of Thailand (2008). Annual Epidemiological Surveillance Report, 122-3.
4. Bureau of Epidemiology, Ministry of Public Health, Thailand (2009). Annual Epidemiological Surveillance Report, 128-9.
5. Jongsuksuntigul P, Imsomboon T (1997). The impact of a decade long opisthorchiasis control program in northeastern, Thailand. Southeast Asian J Trop Med Public Health, 28, 551-7.
6. Kaewpitoon N, Kaewpitoon SJ, Pengsaa P (2008). Opisthorchaisis in Thailand: Review and current status. World J Gastroenterol, 14, 2297-302.
7. Kamsa-ard S, Wiangnon S, Suwanrungruang K, et al (2011). Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: Cholangiocarcinoma. Asian Pac J Cancer Prev, 12, 2209-13.
8. Khuhaprema T, Srivatanakul P (2006). Cancer in Thailand. National Cancer Institute, 4, 37.
9. Lovis L, Mak TK, Phongluxa K, et al (2012). Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial. PLoS Negl Trop Dis, 6, 1726.
10. Melman SD, Steinauer ML, Cunningham C, et al (2009). Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis, 3, 504.
11. Nithikathkul C, Wichmann O, Polseela P, et al (2004). Health behavior associated with Opisthorchis viverrini infection in Khukan district, Si Sa Ket Province, Thailand. Southeast Asian J Trop Med Public Health, 35, 309-12.
12. Poomphakwaen K, Promthet S, Kamsa-ard S, et al (2009). Risk factors for cholangiocarcinoma in Khon Kaen, Thailand: a nested case-control study. Asian Pac J Cancer Prev, 10, 251-7.
13. Prasongwatana J, Laummaunwai P, Boonmars T, Pinlaor S (2012). Viable metacercariae of Opisthorchis viverrini in northeastern Thai cyprinid fish dishes-as part of a rational program for control of O. viverrini-associated cholangiocarcinoma. Parasitol Res, 10, 3154-9.
14. Pungpak S, Bunnag D, Harinasuta T (1985). Studies on the chemotherapy of human opisthorchiasis: effective dose of praziquantel in heavy infection. Southeast Asian J Trop Med Public Hlth, 16, 248-52.
15. Pungpak S, Radomyos P, Radomyos B, et al (1998). Treatment of Opisthorchiasis viverrini and intestinal fluke infections with praziquantel. Southeast Asian J Trop Med Public Hlth, 29, 246-9
16. Rangsin R, Mungthin M, Taamasri P, et al (2009). Incidence and risk factors of Opisthorchis viverrini infections in a rural community in Thailand. Am J Trop Med Hyg, 81, 152-5.
17. Rhongbutsri P, Kitvatanachai S (2002). Survey of the fluke infection rate in Ban Khok Yai village, Khon Kaen, Thailand. J Trop Med Parasitol, 25, 76-8.
18. Saengsawang P, Promthet S, Bradshaw P (2012). Prevalence of OV infection in Yasothon Province, Northeast Thailand. Asian Pacific J Cancer Prev, 13, 3399-402.
19. Sithithaworn P, Andrews RH, Van De N, et al (2012). The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitology Int, 61, 10-6.
20. Sithithaworn P, Haswell-Elkins M (2003).Epidemiology of Opisthorchis viverrini. ActaTropica, 88, 187-94.
21. Sirisinha, S, Tuti S, Tawatsin A, et al (1983). Attempts to induce protective immunity in hamsters against infection by a liver fluke of man (Opisthorchis viverrini). Parasitology, 86, 127-36.
22. Soukhathammavong P, Odermatt P, Sayasone S, et al (2011). Efficacy and safety of mefloquine, artesunate, mefloquine- artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, openlabel, phase 2 trial. Lancet Infect Dis, 11, 110-18.
23. Sripa B, Kaewkes S, Sithithaworn P, et al (2007). Liver fluke induces cholangiocarcinoma. PLoS Med, 4, 201.
24. Sripa B, Brindley PJ, Mulvenna J, et al (2012). The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer. Trends in Parasitol, 28, 395-407.
25. Supanvanich S, Supanvanich K, Pawabut P (1981). Field trial of praziquantel in human opisthorchiasis in Thailand. Southeast Asian J Trop Med Public Health, 12, 598-602.
26. Upatham ES, Viyanant V, Brockelman WY, et al (1988). Rate of re-infection by Opisthorchis viverrini in an endemic northeast Thai community after chemotherapy. Int J Parasitol, 18, 643-9.
27. Upatham ES, Viyanant V, Kurathong S et al (1984). Relationship between prevalence and intensity of Opisthorchis viverrini infection, and clinical symptoms and signs in a rural community in northeast Thailand. Bull World Health Organ, 62, 451-61.
28. Watanapa P, Watanapa WB (2002). Liver fluke-associated cholangiocarcinoma. Br J Surg, 89, 962-70.
29. World Health Organisation (1991). Basic laboratory methods in medical parasitology. World Health Organisation, Geneva.
30. World Health Organisation (2003). Adherence to long-term therapies: evidence for action. World Health Organisation, Geneva.